These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 28186968)

  • 1. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.
    Wu Q; Yan H; Tao SQ; Wang XN; Mou L; Chen P; Cheng XW; Wu WY; Wu ZS
    Oncotarget; 2017 Mar; 8(10):16784-16800. PubMed ID: 28186968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
    Zheng L; Li X; Gu Y; Lv X; Xi T
    Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas.
    Wu Y; Yuan MH; Wu HT; Chen WJ; Zhang ML; Ye QQ; Liu J; Zhang GJ
    Cell Death Dis; 2020 Oct; 11(10):912. PubMed ID: 33099573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity.
    Yang W; Yee AJ
    Biochim Biophys Acta; 2014 Jul; 1843(7):1373-85. PubMed ID: 24594381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
    Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
    Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP4Z1 3'UTR represses migration of human breast cancer cells.
    Wang B; Zheng L; Chou J; Li C; Zhang Y; Meng X; Xi T
    Biochem Biophys Res Commun; 2016 Sep; 478(2):900-7. PubMed ID: 27520371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells.
    Xie Y; Tobin LA; Camps J; Wangsa D; Yang J; Rao M; Witasp E; Awad KS; Yoo N; Ried T; Kwong KF
    Oncogene; 2013 May; 32(19):2442-51. PubMed ID: 22733138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-CATCH Identifies Biologically Active miRNA Regulators of the Pro-Survival Gene XIAP, in Chinese Hamster Ovary Cells.
    Griffith A; Kelly PS; Vencken S; Lao NT; Greene CM; Clynes M; Barron N
    Biotechnol J; 2018 Mar; 13(3):e1700299. PubMed ID: 28976632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of versican 3'-untranslated region modulates endogenous microRNA functions.
    Lee DY; Jeyapalan Z; Fang L; Yang J; Zhang Y; Yee AY; Li M; Du WW; Shatseva T; Yang BB
    PLoS One; 2010 Oct; 5(10):e13599. PubMed ID: 21049042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic p95HER2 regulates Na+-HCO3- cotransporter NBCn1 mRNA stability in breast cancer cells via 3'UTR-dependent processes.
    Gorbatenko A; Olesen CW; Loebl N; Sigurdsson HH; Bianchi C; Pedraz-Cuesta E; Christiansen J; Pedersen SF
    Biochem J; 2016 Nov; 473(21):4027-4044. PubMed ID: 27609814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
    Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
    Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO1 3'UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity.
    Yang J; Li T; Gao C; Lv X; Liu K; Song H; Xing Y; Xi T
    FEBS Lett; 2014 Aug; 588(17):3218-24. PubMed ID: 25017439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Displacement of Bax by BMF Mediates STARD13 3'UTR-Induced Breast Cancer Cells Apoptosis in an miRNA-Depedent Manner.
    Guo X; Xiang C; Zhang Z; Zhang F; Xi T; Zheng L
    Mol Pharm; 2018 Jan; 15(1):63-71. PubMed ID: 29179557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
    Duhachek-Muggy S; Zolkiewska A
    BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.